Professor urges better prevention and care of liver disease to reduce burden

A University of Houston College of Pharmacy professor has published two studies offering a comprehensive look at chronic liver disease in the era of modern antiviral therapies. One study is the first analysis of its economic and human toll; the other examines patient adherence to second-generation antiviral medications, a key factor in disease prevention and treatment in hepatitis C.